Retinal
Vein Occlusion Market – Overview
Retinal vein
occlusion is a commonly occurring vascular disorder of the retina; the increasing frequency has contributed
positively to the development of the market. Focused market reports related to the healthcare industry
among others lately have been made available by Market Research
Future which issues reports on this industry. The Retinal
Vein Occlusion Market Trends is anticipated to expand with a CAGR of 15.56%
to reach USD 14.350 in the duration of the forecast period.
The market’s growth is inspired by the rising number of cases
related to lymphoma and multiple myeloma. Growing prevalence of eye diseases
and prolonged diseases such as diabetes are the main
risk factors for eye diseases. An increasing
level of spending has also enhanced the market because of the research and development by market players. The rise
in the level of anti VEGF drugs has increased the development of the
market to a great extent and is projected to
continue to do so in the forecast period.
Global Competitive Analysis
The
forecast for development and improvement has developed at a rapid pace changing
the market. The vital trends and players have established an optimistic tone
for development. The greatest chances are being
involved and converted to altering the development pace of the market
considerably. By safeguarding the supply and
demand, the competitors can capture novel opportunities for progress.
The stimulus for the market’s growth has
developed the competitive backdrop of the market. The competitors in the market
have been enthused to ideate strategic
road-maps that utilize the constructive market cues.
Allergan
PLC, Bayer, Bristol-Myers Squibb, Ellex Medical Lasers Ltd, GlaxoSmithKline
PLC, IRIDEX Corporation, Lumenis, Novartis AG, NIDEK CO., LTD, Regeneron
Pharmaceuticals, Hoffmann-La Roche AG, Quantel Medical Inc., Topcon Medical
Systems, Inc., ZEISS
Industry
Segments
The retinal
vein occlusion market research is segmented
on the basis of condition, type,
treatment, diagnosis, and end user.
On
the basis of the condition, the market is segmented into ischemic and non-ischemic.
The type based
segmentation of the market comprises of central retinal vein occlusion and
branch retinal artery occlusion.
The basis of
segmentation on treatment comprises of corticosteroid drugs, antivascular
endothelial growth factor, laser retinal photocoagulation, and others.
Based on the
diagnosis, it is segmented into optical
coherence tomography (OCT), fundoscopic examination, fluorescein angiography, and others.
The
market is segmented on the basis of end users into
research & academics centers, hospitals and clinics, and others.
Detailed
Regional Analysis
The
regional analysis of the Retinal
Occlusion Market observes that the Americas region controls the retinal
vein occlusion market due to the growing prevalence of patients, the incidence
of key market companies and development of surgical results. Factors such as
the incidence of a strong economic condition and emphasis of research
institutions on updating technology for new and advanced treatment methods for
retinal vein occlusion are further boosting the market in the region.
The European region controls the second place in the market due to growing
backing from the government, the existence of huge geriatric population, and
escalated healthcare spending. The Asia Pacific region is the most rapidly
mounting market due to an increasing number of emerging nations present in this
region, such as nations like China and India. These nations are inspiring the
development of the retinal vein occlusion market. Meanwhile, the Middle
East & African region is anticipated to control the biggest market share
owing to limited accessibility to medical facilities, and slower development of
the healthcare domain. Though, nations such as Kuwait and Qatar are
concentrating more on the healthcare sector and
emerging medical facilities, which will increase the market of this region.
About US:
Market Research Future
(MRFR) enable customers to unravel the complexity of various industries through
Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research
Reports (3R), Continuous-Feed Research (CFR), and Market Research &
Consulting Services.
Contact us:
Market Research Future (part
of Wantstats Research and Media Private Limited),
99 Hudson Street,5Th Floor,
New York,
New York 10013
